Niagen Bioscience, Inc. - Common Stock (NAGE)

CUSIP: 171077407

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / Common Stock
Shares outstanding
79,963,455
Total 13F shares
3,851,621
Share change
-1,195,776
Total reported value
$14,711,031
Price per share
$3.82
Number of holders
44
Value change
-$3,742,492
Number of buys
22
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 171077407?
CUSIP 171077407 identifies NAGE - Niagen Bioscience, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2017

As of 30 Jun 2017, Niagen Bioscience, Inc. - Common Stock (NAGE) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,851,621 shares. The largest 10 holders included VANGUARD GROUP INC, Tieton Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, North Star Investment Management Corp., Granite Investment Partners, LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ELEMENT CAPITAL MANAGEMENT LLC, Paloma Partners Management Co, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.